Concepedia
Publication | Open Access
Discovery of orally available spirodiketopiperazine-based CCR5 antagonists
17
Citations
10
References
2010
Year
Pharmaceutical SciencePharmacologyPharmacotherapyDrug DevelopmentMedicineDrug Discovery
Identification of a major co-receptor for primary isolates of HIV-1
Hongkui Deng, Rong Liu, Wilfried Ellmeier, +12
Nature
Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral ResponseVirology +4
1996
3.7K
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Tatjana Dragic, Virginia Litwin, Graham P. Allaway, +8
Cd4+ CellsHuman RetrovirusImmunologyAntiviral ResponseImmunologic Mechanism +7
3.2K
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Ghalib Alkhatib, Christophe Combadière, Christopher C. Broder, +4
Science
2.7K
Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro
Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh, +9
Journal of Virology
MedicineHuman RetrovirusImmunologyAntiviral ResponseAntiviral Drug Development +11
2004
221
Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5
Kenji Maeda, Kazuhisa Yoshimura, Shiro Shibayama, +7
Journal of Biological Chemistry
2001
126
Design, Synthesis, and Biological Evaluation of the Combinatorial Library with a New Spirodiketopiperazine Scaffold. Discovery of Novel Potent and Selective Low-Molecular-Weight CCR5 Antagonists
Hiromu Habashita, Masaya Kokubo, Shin-ichi Hamano, +8
Journal of Medicinal Chemistry
Combinatorial ChemistryDrug TargetPharmacotherapyChemical BiologyPharmaceutical Chemistry +16
2006
79
Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc
David A. Price, Duncan Armour, Marcel de Groot, +5
Bioorganic & Medicinal Chemistry Letters
Molecular PharmacologyCcr5 Antagonist MaravirocMedicineHerg AffinityImmunology +3
76
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite
Rena Nishizawa, Toshihiko Nishiyama, Katsuya Hisaichi, +11
BiochemistryMedicineNatural SciencesRational Drug DesignLead Identification +5
47
Chloro-Substituted 3-Alkylamino-4<i>H</i>-1,2,4-benzothiadiazine 1,1-Dioxides as ATP-Sensitive Potassium Channel Activators: Impact of the Position of the Chlorine Atom on the Aromatic Ring on Activity and Tissue Selectivity
Bernard Pirotte, Pascal De Tullio, Quynh-Anh Nguyen, +6
2009
28
Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles
MedicineSpirodiketopiperazine-based Ccr5 AntagonistsClinical PharmacologyPharmacotherapyPharmacology +1
16
Page 1